COVID-19, SARS-CoV-2, whole inactivated virus vaccine, variants of concern, Ad26.COV2.S, Heterologous booster, neutralizing antibodies, delta, omicron, Thailand
COVID-19 vaccine, Ad26.COV2.S booster, heterologous booster, hybrid immunity, omicron variant, Thailand